Cancer BiologybioRxivPreprint
Intratumoral dose heterogeneity promotes adaptive anti-tumor immunity and predicts clinical response to radiopharmaceutical therapy
Maya E. Takashima, Ohyun Kwon, Zachary Ells…·Zachary Scott Morris
This study shows that heterogeneous radiation dose in tumors enhances anti-tumor immunity and correlates with better clinical outcomes in prostate cancer patients.